Earnings call SECO reported Q1 2025 revenues of €37M, flat YoY but up 7% QoQ, with gross margin exceeding 50% guidance and EBITDA margin rebounding to 20%. CLIA software now contributes 13% of sales.
Earnings call SECO reported Q1 2025 revenues of €37M, flat YoY but up 7% QoQ, with gross margin exceeding 50% guidance and EBITDA margin rebounding to 20%. CLIA software now contributes 13% of sales.
Victoria, BC, Canada, Feb. 25, 2013 (GLOBE NEWSWIRE) -- GenoLogics Life Science Software, a leading provider of laboratory information management systems (LIMS) designed for today's omics labs ...